Archive for February 2021
Artificial intelligence (AI) is revolutionising healthcare services
AI may improve clinical research through its ability to better translate RWD into RWE, thus providing more valid evidence of clinical benefits and risks. AI is poised to transform the drug and device development process, helping researchers refine the approval process and significantly cutting both the time and the expense needed to bring products to…
Read MoreNHS has uniquely beneficial healthcare data and real-world evidence to improve oncology outcomes
Real-world evidence generated by the NHS has a broad range of applications in research that can inform regulatory filings by assessing safety and effectiveness, and then the cost-effectiveness, of new treatments. NICE, and other payers, are also actively encouraging and advocating the use of RWE to complement and reduce uncertainty in more traditional evidence in…
Read MoreReal-world evidence in oncology: vitally relevant
Over time oncology practice has seen increased complexity of clinically relevant data recorded for patients, and improved methods of recording (including electronic medical records), which has resulted in increasing volumes of real-world data. Utilising this data has the potential to improve cancer care in many ways including: Help to inform clinical decisions in common settings…
Read MoreInitial real-world evidence shows effectiveness of COVID-19 contact tracing app
The study, assessing the effectiveness of the Spanish DCT app, Radar COVID, used a simulated series of COVID-19 infections in the Canary Islands to understand whether DCT apps work effectively in the real world. The researchers found that over 30% of the population downloaded and utilised the DCT app and that it was able to…
Read More